Whalen HR et al. |
High Intrapatient Tacrolimus Variability Is Associated With Worse Outcomes in Renal Transplantation Using a Low-Dose Tacrolimus Immunosuppressive Regime. |
2017 |
Transplantation |
pmid:26950724
|
Morrissey PE |
Prope tolerance: is it the end or the means? |
2009 |
Transplantation |
pmid:19502973
|
Egawa H et al. |
FK506 conversion therapy in pediatric liver transplantation. |
1994 |
Transplantation |
pmid:7513911
|
Yang CW et al. |
Pharmacological preconditioning with low-dose cyclosporine or FK506 reduces subsequent ischemia/reperfusion injury in rat kidney. |
2001 |
Transplantation |
pmid:11740384
|
Firdaous I et al. |
Pediatric intravenous FK506--how much are we really infusing? |
1994 |
Transplantation |
pmid:7517079
|
Ueno P et al. |
Wound Healing Complications in Kidney Transplant Recipients Receiving Everolimus. |
2017 |
Transplantation |
pmid:27490418
|
Tuteja S et al. |
The effect of gut metabolism on tacrolimus bioavailability in renal transplant recipients. |
2001 |
Transplantation |
pmid:11397967
|
Soccal PM et al. |
Improvement of drug-induced chronic renal failure in lung transplantation. |
1999 |
Transplantation |
pmid:10428288
|
Lee CM et al. |
Outcomes in diabetic patients after simultaneous pancreas-kidney versus kidney alone transplantation. |
1997 |
Transplantation |
pmid:9371670
|
Dhar DK et al. |
Effective prevention of ischemic injury of the dearterialized canine liver by FK506 pretreatment. |
1993 |
Transplantation |
pmid:7506456
|
Nicolai S and Bunyavanich S |
Hypersensitivity reaction to intravenous but not oral tacrolimus. |
2012 |
Transplantation |
pmid:23128975
|
Burke MD et al. |
Inhibition of the metabolism of cyclosporine by human liver microsomes by FK506. |
1990 |
Transplantation |
pmid:1700507
|
Sharif A et al. |
Insulin resistance indexes in renal transplant recipients maintained on tacrolimus immunosuppression. |
2010 |
Transplantation |
pmid:20145524
|
Moutabarrik A et al. |
FK506-induced kidney tubular cell injury. |
1992 |
Transplantation |
pmid:1281562
|
Bolin P et al. |
Optimizing tacrolimus therapy in the maintenance of renal allografts: 12-month results. |
2008 |
Transplantation |
pmid:18622283
|
Uemura T et al. |
Single dose of alemtuzumab induction with steroid-free maintenance immunosuppression in pancreas transplantation. |
2011 |
Transplantation |
pmid:21841541
|
Aw MM et al. |
Calcineurin-inhibitor related nephrotoxicity- reversibility in paediatric liver transplant recipients. |
2001 |
Transplantation |
pmid:11544444
|
Gruessner RW et al. |
Mycophenolate mofetil in pancreas transplantation. |
1998 |
Transplantation |
pmid:9721799
|
Emond JC et al. |
Improved results of living-related liver transplantation with routine application in a pediatric program. |
1993 |
Transplantation |
pmid:7682738
|
Terakura M et al. |
Lymphoid/nonlymphoid compartmentalization of donor leukocyte chimerism in rat recipients of heart allografts, with or without adjunct bone marrow. |
1998 |
Transplantation |
pmid:9721804
|
Kai N et al. |
Prevention of insulitis and diabetes in nonobese diabetic mice by administration of FK506. |
1993 |
Transplantation |
pmid:7682740
|
Jacobson PA et al. |
Novel polymorphisms associated with tacrolimus trough concentrations: results from a multicenter kidney transplant consortium. |
2011 |
Transplantation |
pmid:21206424
|
Kershner RP and Fitzsimmons WE |
Relationship of FK506 whole blood concentrations and efficacy and toxicity after liver and kidney transplantation. |
1996 |
Transplantation |
pmid:8878385
|
Richards KR et al. |
Tacrolimus trough level at discharge predicts acute rejection in moderately sensitized renal transplant recipients. |
2014 |
Transplantation |
pmid:24784360
|
Nolan TJ and Schad GA |
Tacrolimus allows autoinfective development of the parasitic nematode Strongyloides stercoralis. |
1996 |
Transplantation |
pmid:8878405
|
Chung BH et al. |
Suppressive Effect of 1α,25-Dihydroxyvitamin D3 on Th17-Immune Responses in Kidney Transplant Recipients With Tacrolimus-Based Immunosuppression. |
2017 |
Transplantation |
pmid:28107277
|
Klupp J et al. |
Indications of mycophenolate mofetil in liver transplantation. |
2005 |
Transplantation |
pmid:16286893
|
Opelz G and Döhler B |
Influence of immunosuppressive regimens on graft survival and secondary outcomes after kidney transplantation. |
2009 |
Transplantation |
pmid:19300179
|
Rostambeigi N et al. |
Unique cellular and mitochondrial defects mediate FK506-induced islet β-cell dysfunction. |
2011 |
Transplantation |
pmid:21200364
|
Jordan ML et al. |
Tacrolimus rescue therapy for renal allograft rejection--five-year experience. |
1997 |
Transplantation |
pmid:9020321
|
Marin-Casino M et al. |
Significant tacrolimus and dronedarone interaction in a kidney transplant recipient. |
2014 |
Transplantation |
pmid:25243519
|
Hardinger KL et al. |
A randomized, prospective, pharmacoeconomic trial of tacrolimus versus cyclosporine in combination with thymoglobulin in renal transplant recipients. |
2005 |
Transplantation |
pmid:16003231
|
Ericzon BG et al. |
FK506-induced impairment of glucose metabolism in the primate--studies in pancreatic transplant recipients and in nontransplanted animals. |
1992 |
Transplantation |
pmid:1384189
|
Pascual J et al. |
Steroid withdrawal in renal transplant patients on triple therapy with a calcineurin inhibitor and mycophenolate mofetil: a meta-analysis of randomized, controlled trials. |
2004 |
Transplantation |
pmid:15599321
|
Nakazawa Y et al. |
Relationship between in vivo FK506 clearance and in vitro 13-demethylation activity in living-related liver transplantation. |
1998 |
Transplantation |
pmid:9808496
|
Meiser BM et al. |
Tacrolimus or cyclosporine: which is the better partner for mycophenolate mofetil in heart transplant recipients? |
2004 |
Transplantation |
pmid:15446320
|
Jordan ML et al. |
FK506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression. |
1994 |
Transplantation |
pmid:7512293
|
Kashu Y et al. |
The effect of combination splenectomy and low-dose FK506 therapy on graft survival after liver allograft transplantation in rats. |
1996 |
Transplantation |
pmid:8633382
|
Yilmaz MI et al. |
Endothelial functions improve with decrease in asymmetric dimethylarginine (ADMA) levels after renal transplantation. |
2005 |
Transplantation |
pmid:16378057
|
VÃtko S et al. |
Two corticosteroid-free regimens-tacrolimus monotherapy after basiliximab administration and tacrolimus/mycophenolate mofetil-in comparison with a standard triple regimen in renal transplantation: results of the Atlas study. |
2005 |
Transplantation |
pmid:16378069
|
Vacher-Coponat H et al. |
A randomized trial with steroids and antithymocyte globulins comparing cyclosporine/azathioprine versus tacrolimus/mycophenolate mofetil (CATM2) in renal transplantation. |
2012 |
Transplantation |
pmid:22228415
|
Miura S et al. |
Long-term results of spousal renal donor transplants with donor-specific blood transfusions. |
2001 Nov-Dec |
Transplant. Proc. |
pmid:11750463
|
Sato S et al. |
Specificity of therapeutic drug monitoring of tacrolimus in kidney transplant patients. |
1998 |
Transplant. Proc. |
pmid:9636517
|
Pérez-Flores I et al. |
Intracellular ATP levels in CD4+ lymphocytes are a risk marker of rejection and infection in renal graft recipients. |
2009 Jul-Aug |
Transplant. Proc. |
pmid:19715845
|
Tsugita M et al. |
Hepatocytes or liver nonparenchymal cells plus FK 506 prolong liver xenograft survival. |
1994 |
Transplant. Proc. |
pmid:7527969
|
Okamoto M et al. |
Beneficial effect of multiple drug therapy including tacrolimus in clinical renal transplantation. |
2000 |
Transplant. Proc. |
pmid:11119905
|
Ruiz MC et al. |
Effect of early versus delayed calcineurin inhibitor treatment on delayed graft function. |
2003 |
Transplant. Proc. |
pmid:12644096
|
Roman A et al. |
Preliminary results of rescue therapy with tacrolimus and mycophenolate mofetil in lung transplanted patients with bronchiolitis obliterans. |
2002 |
Transplant. Proc. |
pmid:11959227
|
Abe M et al. |
Successful prednisone withdrawal after living-related liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636584
|
Braun F et al. |
Primary tacrolimus immunosuppression in kidney recipients considered "higher immunologic risk". |
2000 |
Transplant. Proc. |
pmid:11120281
|
Stratta RJ et al. |
FK 506 induction and rescue therapy in pancreas transplant recipients. |
1996 |
Transplant. Proc. |
pmid:8623492
|
Woodle ES et al. |
Corticosteroid withdrawal under tacrolimus primary and rescue therapy in renal transplantation: the Chicago experience. |
1999 |
Transplant. Proc. |
pmid:10576053
|
O'Neill EA et al. |
The FK 506-sensitive nature of the interleukin-2 promoter is derived from a specific array of multiple regulatory elements. |
1991 |
Transplant. Proc. |
pmid:1721298
|
Alessiani M et al. |
Total orthotopic small bowel transplantation in swine under FK 506. |
1994 |
Transplant. Proc. |
pmid:7518148
|
Tada H et al. |
Impact of CYP3A5 and MDR1(ABCB1) C3435T polymorphisms on the pharmacokinetics of tacrolimus in renal transplant recipients. |
2005 |
Transplant. Proc. |
pmid:15919447
|
Date K et al. |
Effect of FK 506 on graft survival in rat small intestinal allografts. |
1992 |
Transplant. Proc. |
pmid:1376516
|
Murase N et al. |
Bone marrow augmentation for heart, liver, and small bowel transplantation: prolongation of graft survival and incidence of graft-versus-host disease. |
1995 |
Transplant. Proc. |
pmid:7533386
|
Nakamura K et al. |
Renal transplant recipient experiencing pneumatosis cystoides intestinalis: a case report. |
2003 |
Transplant. Proc. |
pmid:12591410
|
Ishibashi M et al. |
Effect of FK 506 on generation of activated macrophages invading rejected skin allografts in rats: discrepancy of in vitro versus in vivo effects. |
1991 |
Transplant. Proc. |
pmid:1721330
|
Oike F et al. |
Complete withdrawal of immunosuppression in living donor liver transplantation. |
2002 |
Transplant. Proc. |
pmid:12176465
|
Moffatt SD et al. |
Comparative efficacy of liposomal FK506 with FK506. |
1998 |
Transplant. Proc. |
pmid:9865297
|
Ronchetti F et al. |
Intestinal damage evaluation in swine allograft small bowel through hyaluronic acid quantification. |
1997 |
Transplant. Proc. |
pmid:9142293
|
Forgacs B et al. |
Successful conversion to rapamycin for calcineurin inhibitor-related neurotoxicity following liver transplantation. |
2005 |
Transplant. Proc. |
pmid:15919502
|
Yagihashi A et al. |
HLA matching effect in liver transplantation. |
1992 |
Transplant. Proc. |
pmid:1281569
|
McCauley J et al. |
Renal transplantation under FK 506 in patients with previous loss of renal function due to hemolytic uremic syndrome. |
1991 |
Transplant. Proc. |
pmid:1721362
|
Zeevi A et al. |
Correlation between bioassayed plasma levels of FK 506 and lymphocyte growth from liver transplant biopsies with histological evidence of rejection. |
1991 |
Transplant. Proc. |
pmid:1703341
|
Sánchez-Fructuoso AI et al. |
Daclizumab induction as an immunosuppressive regimen for renal transplant recipients from non-heart-beating donors. |
2003 |
Transplant. Proc. |
pmid:12962759
|
Miyazawa H et al. |
Graft immunomodulation by donor irradiation and recipient-specific bone marrow cells in rat small bowel transplantation. |
2002 |
Transplant. Proc. |
pmid:12072357
|
Coupes BM et al. |
Tacrolimus monotherapy in renal transplantation: four-year data. |
2002 |
Transplant. Proc. |
pmid:12176506
|
Renner FC et al. |
Tacrolimus intoxication resolved by gastrointestinal bleeding: case report. |
2007 |
Transplant. Proc. |
pmid:17362773
|
Jeong HJ et al. |
Vascular endothelin, TGF-beta, and PDGF expression in FK506 nephrotoxicity of rats. |
1998 |
Transplant. Proc. |
pmid:9838576
|
Lohmann R et al. |
Quadruple induction therapy including antithymocyte globulin or interleukin-2 receptor antibody or FK 506-based induction therapy after liver transplantation. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083151
|
Cho WH et al. |
Basiliximab does not reduce the early rejection incidence in high-risk kidney recipients under tacrolimus-based immunosuppression. |
2008 |
Transplant. Proc. |
pmid:18790201
|
Misao T et al. |
Effect of donor splenocyte transfusion with a simultaneous single injection of tacrolimus on lung allografts. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123153
|
Inagaki K et al. |
Effects of FK506 and 15-deoxyspergualin in rat orthotopic liver transplantation. |
1989 |
Transplant. Proc. |
pmid:2468210
|
Scantlebury V et al. |
New onset of diabetes in FK 506 vs cyclosporine-treated kidney transplant recipients. |
1991 |
Transplant. Proc. |
pmid:1721395
|
Uchida J et al. |
Conversion of stable kidney transplant recipients from a twice-daily prograf to a once-daily tacrolimus formulation: a short-term study on its effects on glucose metabolism. |
2012 |
Transplant. Proc. |
pmid:22310596
|
Hesse CJ et al. |
The value of routine monitoring of mycophenolic acid plasma levels after clinical heart transplantation. |
2001 |
Transplant. Proc. |
pmid:11377487
|
Uchida K et al. |
Usefulness of monitoring of AUC(0-4h) during the induction period of immunosuppressive therapy with tacrolimus after renal transplantation. |
2002 |
Transplant. Proc. |
pmid:12176556
|
Lemahieu WP et al. |
Different evolution of trough and dose levels during the first year after transplantation for tacrolimus versus cyclosporine. |
2005 |
Transplant. Proc. |
pmid:15964336
|
Langrehr JM et al. |
Indefinite small bowel allograft survival after limited immunosuppressive therapy is not due to specific hyporesponsiveness. |
1991 |
Transplant. Proc. |
pmid:1721425
|
Honbo T et al. |
The oral dosage form of FK-506. |
1987 |
Transplant. Proc. |
pmid:2445068
|
Holt DW et al. |
Therapeutic monitoring of sirolimus: its contribution to optimal prescription. |
2003 |
Transplant. Proc. |
pmid:12742490
|
Sundberg AK et al. |
Conversion from cyclosporine to tacrolimus is preferred by pediatric renal transplant recipients: a focus on opinions and outcomes. |
2002 |
Transplant. Proc. |
pmid:12176640
|
Moray G et al. |
Comparison of histidine-tryptophan-ketoglutarate and University of Wisconsin in living-donor liver transplantation. |
2006 |
Transplant. Proc. |
pmid:17175334
|
Nojima M et al. |
Immunosuppression Modification by Everolimus With Minimization of Calcineurin Inhibitors Recovers Kidney Graft Function Even in Patients With Very Late Conversion and Also With Poor Graft Function. |
|
Transplant. Proc. |
pmid:28104155
|
Cailhier JF et al. |
CMV in kidney transplants in the tacrolimus-mycophenolate era. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267255
|
Perego C et al. |
Study of the immunosuppressive effect of SMS 201-995 and its synergic action with FK 506. |
1998 |
Transplant. Proc. |
pmid:9723434
|
Timmermann W et al. |
Noninvasive videomicroscopic monitoring of rat small bowel rejection. |
1998 |
Transplant. Proc. |
pmid:9745537
|
Laftavi MR et al. |
The role of antibiotic prophylaxis in the new era of immunosuppression. |
2011 |
Transplant. Proc. |
pmid:21440753
|
Percy C et al. |
Impact of Acute Infection Requiring Hospitalization on Tacrolimus Blood Levels in Kidney Transplant Recipients. |
2017 |
Transplant. Proc. |
pmid:29149962
|
Kupferman JC et al. |
Activation of the renal renin-angiotensin system by cyclosporine A and FK 506 in the rat. |
1994 |
Transplant. Proc. |
pmid:7524224
|
Roat MI et al. |
Treatment of Cogan's syndrome with FK 506: a case report. |
1991 |
Transplant. Proc. |
pmid:1721457
|
Kelley M et al. |
Change in oral absorption of tacrolimus in a liver transplant recipient after reversal of jejunoileal bypass: case report. |
2005 |
Transplant. Proc. |
pmid:16213338
|
Meiser BM et al. |
Continuous infusion of angiopeptin significantly reduces accelerated graft vessel disease induced by FK 506 in a rat heart allograft model. |
1992 |
Transplant. Proc. |
pmid:1384201
|
Ochiai T et al. |
Effect of a new immunosuppressive agent, FK 506, on heterotopic cardiac allotransplantation in the rat. |
1987 |
Transplant. Proc. |
pmid:2484094
|
McCauley J et al. |
Long-term lipid metabolism in combined kidney-pancreas transplant recipients under tacrolimus immunosuppression. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267475
|
Pinho-Apezzato ML et al. |
Multiple clinical presentations of lymphoproliferative disorders in pediatric liver transplant recipients: a single-center experience. |
2010 |
Transplant. Proc. |
pmid:20620519
|
Undre NA et al. |
Pharmacokinetics of tacrolimus (FK506) in primary orthotopic heart transplant patients. |
1998 |
Transplant. Proc. |
pmid:9636451
|
Takaya S et al. |
Positive crossmatch in primary human liver allografts under cyclosporine or FK 506 therapy. |
1991 |
Transplant. Proc. |
pmid:1703691
|